{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:46:00Z","timestamp":1790682360580,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["bprch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.beha.2013.09.005","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T20:08:51Z","timestamp":1380658131000},"page":"377-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Refractory anemia with ring sideroblasts"],"prefix":"10.1016","volume":"26","author":[{"given":"Luca","family":"Malcovati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2013.09.005_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM197501232920405","article-title":"Sideroblasts, siderocytes, and sideroblastic anemia","volume":"292","author":"Cartwright","year":"1975","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2013.09.005_bib2","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3324\/haematol.13405","article-title":"Diagnosis and classification of myelodysplastic syndrome: International Working Group on morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts","volume":"93","author":"Mufti","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2013.09.005_bib3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.0007-1048.2002.03378.x","article-title":"Sideroblastic anaemias","volume":"116","author":"Alcindor","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.09.005_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1182\/blood.V11.3.250.250","article-title":"Chronic refractory anemia with sideroblastic bone marrow; a study of four cases","volume":"11","author":"Bjorkman","year":"1956","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.09.005_bib6","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib7","doi-asserted-by":"crossref","first-page":"24437","DOI":"10.1074\/jbc.C100141200","article-title":"A\u00a0human mitochondrial ferritin encoded by an intronless gene","volume":"276","author":"Levi","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beha.2013.09.005_bib8","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1182\/blood-2002-07-2006","article-title":"Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia","volume":"101","author":"Cazzola","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib9","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1182\/blood.V84.11.3915.bloodjournal84113915","article-title":"X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley","volume":"84","author":"Cotter","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/hmg\/8.5.743","article-title":"Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA\/A)","volume":"8","author":"Allikmets","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beha.2013.09.005_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ng.359","article-title":"Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia","volume":"41","author":"Guernsey","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2013.09.005_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.leukres.2006.06.005","article-title":"Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts)","volume":"31","author":"Steensma","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2013.09.005_bib13","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2003-07-2446","article-title":"Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome","volume":"103","author":"Gattermann","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib14","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1182\/blood-2002-06-1825","article-title":"Mitochondrial DNA mutations in patients with myelodysplastic syndromes","volume":"101","author":"Shin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood-2005-12-4769","article-title":"Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype","volume":"108","author":"Pellagatti","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib16","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1182\/blood.V106.11.3444.3444","article-title":"Mitochondrial ferritin expression and clonality of hematopoiesis in patients with refractory anemia with ringed sideroblasts","volume":"106","author":"Della Porta","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib17","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2013.09.005_bib18","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1182\/blood-2011-09-377275","article-title":"Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms","volume":"118","author":"Malcovati","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.beha.2013.09.005_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1182\/blood-2011-09-377994","article-title":"SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value","volume":"119","author":"Patnaik","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib21","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1182\/blood-2011-12-400994","article-title":"Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes","volume":"119","author":"Damm","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib22","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood-2011-12-399337","article-title":"Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes","volume":"119","author":"Thol","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2012-09-399725","article-title":"Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms","volume":"121","author":"Cazzola","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib25","doi-asserted-by":"crossref","first-page":"e1970","DOI":"10.1371\/journal.pone.0001970","article-title":"The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts","volume":"3","author":"Boultwood","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.beha.2013.09.005_bib26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/leu.2012.298","article-title":"The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts","volume":"27","author":"Nikpour","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2013.09.005_bib27","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2012-05-430876","article-title":"SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes","volume":"120","author":"Visconte","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2141.1990.tb02536.x","article-title":"Two types of acquired idiopathic sideroblastic anaemia (AISA)","volume":"74","author":"Gattermann","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.09.005_bib29","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria. A basis for clinical decision-making","volume":"23","author":"Malcovati","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2013.09.005_bib30","first-page":"1596","article-title":"Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes","volume":"91","author":"Germing","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2013.09.005_bib31","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","first-page":"89","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.beha.2013.09.005_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.V71.2.305.305","article-title":"Natural history of idiopathic refractory sideroblastic anemia","volume":"71","author":"Cazzola","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3324\/haematol.2012.077446","article-title":"Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1","volume":"98","author":"Ambaglio","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2013.09.005_bib34","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib35","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib36","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","article-title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes","volume":"25","author":"Malcovati","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2013.09.005_bib37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood.V92.1.68.413k23_68_75","article-title":"Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients","volume":"92","author":"Hellstrom-Lindberg","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood-2003-07-2252","article-title":"Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial","volume":"104","author":"Casadevall","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib39","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1182\/blood-2009-03-211797","article-title":"Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)","volume":"114","author":"Greenberg","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1365-2141.1997.4013211.x","article-title":"Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model","volume":"99","author":"Hellstrom-Lindberg","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.09.005_bib41","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2141.2003.04153.x","article-title":"A\u00a0validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life","volume":"120","author":"Hellstrom-Lindberg","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.09.005_bib42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMp048266","article-title":"Myelodysplastic syndromes\u2013coping with ineffective hematopoiesis","volume":"352","author":"Cazzola","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2013.09.005_bib43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3324\/haematol.2010.033506","article-title":"Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome","volume":"96","author":"Della Porta","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2013.09.005_bib44","article-title":"A\u00a0prognostic model for predicting the impact of comorbidities on survival of patients with myelodysplastic syndromes","volume":"110","author":"Della Porta","year":"2007","journal-title":"ASH Annu Meet Abstr"},{"key":"10.1016\/j.beha.2013.09.005_bib45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood-2004-01-0338","article-title":"A\u00a0decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome","volume":"104","author":"Cutler","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","article-title":"Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study","volume":"10","author":"Fenaux","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beha.2013.09.005_bib47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2005.05747.x","article-title":"Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic\/myeloproliferative disease of older adults","volume":"131","author":"Shaw","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2013.09.005_bib48","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2006-02-005751","article-title":"Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation","volume":"108","author":"Szpurka","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib49","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2009-05-222331","article-title":"Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis","volume":"114","author":"Malcovati","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.09.005_bib50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3324\/haematol.11581","article-title":"JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis","volume":"93","author":"Schmitt-Graeff","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2013.09.005_bib51","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.3324\/haematol.2012.072538","article-title":"High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic\/myeloproliferative neoplasms","volume":"98","author":"Jeromin","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2013.09.005_bib52","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/leu.2008.249","article-title":"UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation","volume":"23","author":"Szpurka","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2013.09.005_bib53","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3324\/haematol.2011.053918","article-title":"Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis","volume":"97","author":"Broseus","year":"2012","journal-title":"Haematologica"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T10:15:05Z","timestamp":1716027305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692613000534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1521692613000534"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2013.09.005","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractory anemia with ring sideroblasts","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2013.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}